About: Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
Creator	Gov, Zhang, Shuyang Au, Argentina, Chattu, Vijay Adisesh, Anil Bhaskar, Sonu Maisch, Bernhard Nsw, Thomas, Pravin Walker, Antony Bhaskar@health, Sonu Pai, Anupama Alvarado, Negman Barsam, Sarah Rastogi, Aarushi Riahi, Anis Varun, Chakrakodi Acampa, Maurizio Alfici, Rodriguez Cruz, Godoy
Source	Medline; PMC
abstract	Patients with cardiovascular disease and diabetes are at potentially higher risk of infection and fatality due to COVID-19. Given the social and economic costs associated with disability due to these conditions, it is imperative that specific considerations for clinical management of these patients be observed. Moreover, the reorganization of health services around the pandemic response further exacerbates the growing crisis around limited access, treatment compliance, acute medical needs, and mental health of patients in this specific subgroup. Existing recommendations and guidelines emanating from respective bodies have addressed some of the pressure points; however, there are variations and limitations vis a vis patient with multiple comorbidities such as obesity. This article will pull together a comprehensive assessment of the association of cardiovascular disease, diabetes, obesity and COVID-19, its impact on the health systems and how best health systems can respond to mitigate current challenges and future needs. We anticipate that in the context of this pandemic, the cardiovascular disease and diabetes patients need a targeted strategy to ensure the harm to this group does not translate to huge costs to society and to the economy. Finally, we propose a triage and management protocol for patients with cardiovascular disease and diabetes in the COVID-19 settings to minimize harm to patients, health systems and healthcare workers alike.
has issue date	2020-06-16(xsd:dateTime)
bibo:doi	10.3389/fcvm.2020.00112
bibo:pmid	32613010
has license	cc-by
sha1sum (hex)	f2653a86b10042592c2b4b238dba244bf9743ac7
schema:url	https://doi.org/10.3389/fcvm.2020.00112
resource representing a document's title	Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
has PubMed Central identifier	PMC7308556
has PubMed identifier	32613010
schema:publication	Front Cardiovasc Med
resource representing a document's body	covid:f2653a86b10042592c2b4b238dba244bf9743ac7#body_text
is schema:about of	named entity 'Settings' named entity 'heterogeneity' named entity 'life-threatening' named entity 'diabetes' named entity 'primary health care' named entity 'COVID' named entity 'COVID-19' named entity 'BMI' named entity 'Anticoagulation' named entity 'cardiovascular events' named entity 'obesity' named entity 'diabetes' named entity 'clinical guidelines' named entity 'PPE' named entity 'cardiovascular disease' named entity 'COVID' named entity 'mortality rates' named entity 'global pandemic' named entity 'public health interventions' named entity 'obesity' named entity 'neutrophil' named entity 'contra-indicated' named entity 'sick day' named entity 'prophylactic therapy' named entity 'Myocardial injury' named entity 'comorbidities' named entity 'STEMI' named entity 'COVID-19' named entity 'clinical outcomes' named entity 'diabetes' named entity 'medical attention' named entity 'COVID-19' named entity 'VTE' named entity 'United Kingdom' named entity 'infection' named entity 'patient outcomes' named entity 'electrocardiogram' named entity 'healthcare workers' named entity 'reperfusion therapy' named entity 'COVID' named entity 'surgical face masks' named entity 'social distancing' named entity 'outpatient' named entity 'Center for Disease Control and Prevention' named entity 'telehealth' named entity 'CDC' named entity 'vomiting' named entity 'glycaemic index' named entity 'morbidity' named entity 'obesity' named entity 'shortness of breath' named entity 'prophylaxis' named entity 'COVID' named entity 'obesity' named entity 'home isolation' named entity 'comorbidities' named entity 'venous thromboembolism' named entity 'ISPAD' named entity 'ketones' named entity 'adiposity' named entity 'QTc prolongation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software